MentionFox
Home › funding signals › Torpedo Therapeutics
Accelerator · announced

Torpedo Therapeutics (YC W22) — High-precision, closed-loop neuromodulation devices

We are building high-precision implantable neuromodulation devices that can sense and stimulate neural activity in the brain with the goal of transforming the efficacy and adoption of deep brain stimulation (DBS), an existing FDA-approved therapy used to treat Parkinson’s, essential tremor and epilepsy.

Torpedo Therapeutics is a Y Combinator company in the Winter 2022 batch. Its directory entry describes it as: High-precision, closed-loop neuromodulation devices. The founder listed is Ingrid van Welie (Founder) (Y Combinator directory entry, February 17, 2022).

6 more companies from YC Winter 2022 ↓

Run the free check on Torpedo Therapeutics →

Sell to companies like Torpedo Therapeutics? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Torpedo Therapeutics

New accelerator entry · 2022-02-17 · the record

Winter 2022
batch
5
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchWinter 2022
Announced2022-02-17
StageEarly
StatusActive
Team size5
IndustryHealthcare
Sub-industryHealthcare -> Medical Devices
SectorsNeurotechnology, Medical Devices, Biotech
RegionsUnited States of America, America / Canada
BasedBoston, MA, USA
HiringNo
Sitehttps://www.torpedotherapeutics.com
Previously known asNeural Dynamics Technologies LLC, Neural Dynamics, Neural Dynamics Technologies, Neural Dynamics Technologies Inc.

Pitching, partnering or investing alongside them? See who really runs and owns Torpedo Therapeutics.

Free to see. No signup.

Keep reading

More on Torpedo Therapeutics and the records around it.

Also in YC Winter 2022

Same batch, Healthcare first.

What do you want to do with Torpedo Therapeutics?

Get the full cited report on Torpedo Therapeutics

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Torpedo Therapeutics: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

We are building high-precision implantable neuromodulation devices that can sense and stimulate neural activity in the brain with the goal of transforming the efficacy and adoption of deep brain stimulation (DBS), an existing FDA-approved therapy used to treat Parkinson’s, essential tremor and epilepsy.

Want the whole picture on Torpedo Therapeutics?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Torpedo Therapeutics: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Torpedo Therapeutics covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Torpedo Therapeutics: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for Torpedo Therapeutics. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups Medical device and diagnostics startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

Torpedo Therapeutics: Accepted into Y Combinator Winter 2022
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-torpedo-therapeutics
Last updated 2026-10-20
Primary record: Y Combinator directory entry
Torpedo Therapeutics (YC W22) — High-precision, closed-loop neuromodulation devices. MentionFox, 2026-10-20. https://mentionfox.com/funding/yc-torpedo-therapeutics